Drug intelligence / Profile preview

Ciscare

Development stage
Unknown
Lead developer
Procare Health Iberia
Modality
Hydrogel Systems → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Administration
Oral
01

Overview

Ciscare is a non-hormonal topical vaginal gel developed by Procare Health for the prevention and adjuvant treatment of recurrent cystitis and genital infections. The product utilizes a niosomal delivery system to provide hydration and barrier protection to the vaginal mucosa. Its primary mechanism involves the restoration of the vaginal microbiota through the prebiotic alpha-glucan oligosaccharide (Bioecolia), which promotes the growth of beneficial *Lactobacillus* species. By strengthening the vaginal mucosal barrier and maintaining a healthy microbial environment, Ciscare prevents the migration and ascent of uropathogenic bacteria, such as *Escherichia coli*, from the vagina to the urinary tract. It is typically regulated as a medical device and is indicated for women prone to frequent urinary tract infections.

Brand names
Ciscare
Other names
Ciscare Vaginal Gel

Beyond the preview

Go deeper on Ciscare.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ciscare.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call